Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Guy

Showing results (271-280 of 322) with videos related to

Pageof 33
Sort By:
Endocrinology|August 15, 2014
Repair-related activation of hedgehog signaling in stromal cells promotes intrahepatic hypothyroidismBrittany N Bohinc, Gregory Michelotti, Guanhua Xie, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2021
Cross-linkage between bacterial taxonomy and gene functions: a study of metagenome-assembled genomes of gut microbiota in adult non-alcoholic fatty liver diseaseClemence M Canivet, Norma David, Helene Pailhoriès, et al.
Hepatology (Baltimore, Md.)|February 27, 2019
NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic SteatohepatitisStephen A Harrison, Stephen J Rossi, Angelo H Paredes, et al.
Gastroenterology|March 13, 1998
Abnormal intestinal intraepithelial lymphocytes in refractory sprueC Cellier, N Patey, L Mauvieux, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2018
Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic SteatohepatitisRohit Loomba, Anjali Jain, Anna Mae Diehl, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 16, 2016
Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic SteatohepatitisJu Dong Yang, Manal F Abdelmalek, Cynthia D Guy, et al.
Lancet (London, England)|November 16, 2019
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialStephen A Harrison, Mustafa R Bashir, Cynthia D Guy, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 8, 2013
Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosisKaren D Corbin, Manal F Abdelmalek, Melanie D Spencer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2020
Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosisDaniela S Allende, Samer Gawrieh, Oscar W Cummings, et al.
Hepatology (Baltimore, Md.)|November 25, 2015
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiotaJérôme Boursier, Olaf Mueller, Matthieu Barret, et al.
Pageof 33

Showing results (271-280 of 322) with videos related to

Sort By:
Pageof 33
Endocrinology|August 15, 2014
Repair-related activation of hedgehog signaling in stromal cells promotes intrahepatic hypothyroidismBrittany N Bohinc, Gregory Michelotti, Guanhua Xie, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2021
Cross-linkage between bacterial taxonomy and gene functions: a study of metagenome-assembled genomes of gut microbiota in adult non-alcoholic fatty liver diseaseClemence M Canivet, Norma David, Helene Pailhoriès, et al.
Hepatology (Baltimore, Md.)|February 27, 2019
NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic SteatohepatitisStephen A Harrison, Stephen J Rossi, Angelo H Paredes, et al.
Gastroenterology|March 13, 1998
Abnormal intestinal intraepithelial lymphocytes in refractory sprueC Cellier, N Patey, L Mauvieux, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2018
Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic SteatohepatitisRohit Loomba, Anjali Jain, Anna Mae Diehl, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 16, 2016
Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic SteatohepatitisJu Dong Yang, Manal F Abdelmalek, Cynthia D Guy, et al.
Lancet (London, England)|November 16, 2019
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialStephen A Harrison, Mustafa R Bashir, Cynthia D Guy, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 8, 2013
Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosisKaren D Corbin, Manal F Abdelmalek, Melanie D Spencer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2020
Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosisDaniela S Allende, Samer Gawrieh, Oscar W Cummings, et al.
Hepatology (Baltimore, Md.)|November 25, 2015
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiotaJérôme Boursier, Olaf Mueller, Matthieu Barret, et al.
Pageof 33